Turning to cytokines, interleukin-1 (IL-1) has been extensively characterized as a pivotal mediator in the inflammatory phase of myocardial ischemia–reperfusion injury, contributing to both pathological and reparative processes. Here, IL1B is linked to myocardial ischemia.